{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:31:19Z","timestamp":1791865879347,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ygyno.2021.01.001","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:12:51Z","timestamp":1610928771000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer"],"prefix":"10.1016","volume":"161","author":[{"given":"Olga V.","family":"Novikova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir B.","family":"Nosov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A.","family":"Panov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena G.","family":"Novikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ksenia V.","family":"Krasnopolskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia Yu.","family":"Andreeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey S.","family":"Shevchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2021.01.001_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.001_bb0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.17116\/terarkh201688160-66","article-title":"Results of malignancy detection during prophylactic medical examinations in 2013\u20132014","volume":"88","author":"Aleksandrova","year":"2016","journal-title":"Ter. Arkh."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long- term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2021.01.001_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0090-8258(85)90135-0","article-title":"Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy?","volume":"20","author":"Bokhman","year":"1985","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.08.011","article-title":"Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis","volume":"207","author":"Gallos","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0030","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2012.01.003","article-title":"Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review","volume":"125","author":"Gunderson","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.001_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ijgo.12882","article-title":"A systematic review and meta-analysis of prognostic factors for remission in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma","volume":"146","author":"Guillon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2265.1982.tb01625.x","article-title":"Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD","volume":"17","author":"Nilsson","year":"1982","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0045","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/annonc\/mdq463","article-title":"Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women","volume":"22","author":"Minig","year":"2011","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.001_bb0050","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3802\/jgo.2019.30.e47","article-title":"Six months response rate of combined oral medroxyprogesterone\/levonorgestrel-intrauterine system for early-stage endometrial cancer in young women: a Korean Gynecologic-Oncology Group Study","volume":"30","author":"Kim","year":"2019","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","article-title":"Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer","volume":"29","author":"Chae","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.001_bb0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AOG.0000000000002390","article-title":"Treatment of low- risk endometrial cancer and complex atypical hyperplasia with the levonorgestrel-releasing intrauterine device","volume":"131","author":"Pal","year":"2018","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.001_bb0065","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.3802\/jgo.2019.30.e57","article-title":"Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study","volume":"30","author":"ULR","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.001_bb0070","doi-asserted-by":"crossref","first-page":"103.e1","DOI":"10.1016\/j.ajog.2019.12.273","article-title":"Progestin therapy for obese women with complex atypical hyperplasia: levonorgestrel-releasing intrauterine device vs systemic therapy","volume":"223","author":"Mandelbaum","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2020-001309","article-title":"Improving response to progestin treatment of low-grade endometrial cancer","author":"Baxter","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.001_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2013.11.028","article-title":"Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis","volume":"101","author":"Koskas","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.ejca.2012.09.017","article-title":"Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002)","volume":"49","author":"Park","year":"2013","journal-title":"Eur. J. Cancer"},{"issue":"19","key":"10.1016\/j.ygyno.2021.01.001_bb0090","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2015.06.046","article-title":"Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer","volume":"132","author":"Chen","year":"2016","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.001_bb0100","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.3802\/jgo.2018.29.e21","article-title":"Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?","volume":"29","author":"Yamagami","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3802\/jgo.2014.25.3.214","article-title":"Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia","volume":"25","author":"Shan","year":"2014","journal-title":"J. Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.01.001_bb0110","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.3802\/jgo.2019.30.e90","article-title":"Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients","volume":"30","author":"Mitsuhashi","year":"2019","journal-title":"J. Gynecol. Oncol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.01.001_bb0115","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/1471-0528.16108","article-title":"Metformin plus megestrol acetate compared with megestrol acetate alone as fertility-sparing treatment in patients with atypical endometrial hyperplasia and well-differentiated endometrial cancer: a randomised controlled trial","volume":"127","author":"Yang","year":"2020","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.001_bb0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ygyno.2020.02.008","article-title":"The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia\/endometrial intraepithelial neoplasia or endometrial cancer: little impact on response and low live-birth rates","volume":"157","author":"Acosta-Torres","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0125","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/ijgc-00009577-200509000-00041","article-title":"Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection","volume":"15","author":"Mazzon","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.01.001_bb0130","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jmig.2015.06.004","article-title":"Hysteroscopic resection in fertility- sparing surgery for atypical hyperplasia and endometrial cancer: safety and efficacy","volume":"22","author":"De Marzi","year":"2015","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0135","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e2","article-title":"Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer","volume":"28","author":"Falcone","year":"2017","journal-title":"J. Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.001_bb0140","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jmig.2018.07.001","article-title":"Hysteroscopic endometrial focal resection followed by Levonorgestrel intrauterine device insertion as a fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial Cancer: a retrospective study","volume":"26","author":"Giampaolino","year":"2019","journal-title":"J. Minim. Invasive Gynecol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.001_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ygyno.2019.01.014","article-title":"Treatment efficiency of comprehensive hysteroscopic evaluation and lesion resection combined with progestin therapy in young women with endometrial atypical hyperplasia and endometrial cancer","volume":"153","author":"Yang","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.ygyno.2021.01.001_bb0150","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/aogs.13587","article-title":"Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: a systematic review","volume":"98","author":"Travaglino","year":"2019","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0155","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/PGP.0000000000000518","article-title":"Endometrial carcinoma diagnosis: use of FIGO grading and genomic subcategories in clinical practice: recommendations of the International Society of Gynecological Pathologists","volume":"38","author":"Soslow","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"10","key":"10.1016\/j.ygyno.2021.01.001_bb0160","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/1471-0528.14491","article-title":"Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well-differentiated endometrial adenocarcinoma: a consecutive case series","volume":"124","author":"Zakhour","year":"2017","journal-title":"BJOG."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.001_bb0165","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.001_bb0170","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/AOG.0b013e31827a0643","article-title":"Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer","volume":"121","author":"Park","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ygyno.2021.01.001_bb0175","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/ijgc-2018-000081","article-title":"Impact of treatment duration in fertility-preserving management of endometrial cancer or atypical endometrial hyperplasia","volume":"29","author":"Wang","year":"2019","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.01.001_bb0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jog.13473","article-title":"Efficacy of medroxypro- gesterone acetate treatment and retreatment for atypical endometrial hyperplasia and endometrial cancer","volume":"44","author":"Tamauchi","year":"2018","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"5","key":"10.1016\/j.ygyno.2021.01.001_bb0185","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3892\/ol.2012.602","article-title":"Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma","volume":"3","author":"Fujiwara","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ygyno.2021.01.001_bb0190","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/IGC.0000000000000098","article-title":"Fertility-preserving treatment in young women with endometrial adenocarcinoma: a long-term cohort study","volume":"24","author":"Wang","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.01.001_bb0195","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/IGC.0b013e31827c18a1","article-title":"The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia","volume":"23","author":"Ichinose","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.01.001_bb0200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0002-9378(94)70290-X","article-title":"Survival of breast cancer patients after subsequent term pregnancy: \u201chealthy mother effect\u201d","volume":"170","author":"Sankila","year":"1994","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821000019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:56:58Z","timestamp":1758772618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821000019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0090825821000019"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}